First Heartland Consultants’s Idexx Laboratories IDXX Stock Holding History

First Heartland Consultants’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-392	Closed	-$214K	–	365
2022 Q1	$214K	Hold	392	–	–	0.03%	327
2021 Q4	$258	Sell	392 -121	-24%	-$76K	0.01%	306
2021 Q3	$319K	Buy	513 +45	+10%	+$30.2K	0.05%	265
2021 Q2	$296K	Buy	468 +20	+4%	+$11K	0.04%	286
2021 Q1	$219K	Buy	448 +31	+7%	+$15.5K	0.03%	356
2020 Q4	$208K	Buy	+417	New	+$187K	0.03%	326
2015 Q1	–	Sell	-3,468	Closed	-$257K	–	262
2014 Q4	$257K	Buy	+3,468	New	+$243K	0.11%	201

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

First Heartland Consultants's IDXX Position: Q2 2022 in Review

First Heartland Consultants sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 392 shares — an estimated $214K sold.

First Heartland Consultants first reported a position in IDXX in Q4 2014 and held it in 7 quarters. The position peaked at $319K in Q3 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

First Heartland Consultants reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
First Heartland Consultants sold 392 Idexx Laboratories shares in Q2 2022, an estimated $214K.
First Heartland Consultants first reported a position in Idexx Laboratories in Q4 2014 and held it in 7 quarters.
First Heartland Consultants's Idexx Laboratories position peaked at $319K in Q3 2021.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on First Heartland Consultants's 13F filing for Q2 2022, filed 12 Jul 2022.